Front. Ag. Neurosci Frontiers in Aging Neuroscience Front. Ag. Neurosci 1663-4365 Frontiers Research Foundation 10.3389/fnagi.2012.00008 Neuroscience Original Research Effects of Aging and Anatomic Location on Gene Expression in Human Retina Cai Hui 1 Fields Mark A. 1 Hoshino Risa 1 Priore Lucian V. Del 1 * † 1Department of Ophthalmology, Harkness Eye Institute, Columbia University, New York NY, USA

Edited by: Dafin F. Muresanu, University of Medicine and Pharmacy “Iuliu Hatieganu,” Romania

Reviewed by: Hari S. Sharma, Uppsala University, Sweden; Daniel Ortuño-Sahagun, Centro Universitario de Ciencias Biológicas y Agropecuarias, Mexico; Federico Antonio, University of Siena, Italy

*Correspondence: Lucian V. Del Priore, Department of Ophthalmology, Harkness Eye Institute, Columbia University, 635 West 165th Street, New York, NY, USA.

†Present address: Lucian V. Del Priore, Department of Ophthalmology, Storm Eye Institute, Medical University of South Carolina, 167 Ashley Avenue, Charleston, SC 29425, USA. e-mail: lvdelpriore@gmail.com

 31 05 2012 2012 4 8 08 06 2011 10 05 2012 Copyright © 2012 Cai, Fields, Hoshino and Priore. 2012

This is an open-access article distributed under the terms of the Creative Commons Attribution Non Commercial License, which permits non-commercial use, distribution, and reproduction in other forums, provided the original authors and source are credited.

Objective: To determine the effects of age and topographic location on gene expression in human neural retina. Methods: Macular and peripheral neural retina RNA was isolated from human donor eyes for DNA microarray and quantitative RT-PCR analyses. Results: Total RNA integrity from human donors was preserved. Hierarchical clustering analysis demonstrates that the gene expression profiles of young, old, macula, and peripheral retina cluster into four distinct groups. Genes which are highly expressed in macular, peripheral, young, or old retina were identified, including inhibitors of Wnt Signaling Pathway (DKK1, FZD10, and SFRP2) which are preferably expressed in the periphery. Conclusion: The transcriptome of the human retina is affected by age and topographic location. Wnt pathway inhibitors in the periphery may maintain peripheral retinal cells in an undifferentiated state. Understanding the effects of age and topographic location on gene expression may lead to the development of new therapeutic interventions for age-related eye diseases.

 human retina macula peripheral aging DNA microarray gene expression Wnt signaling pathway Introduction

In the normal human eye the neural retina develops from mesoderm and forms a multilaminated structure with highly specialized functions for light detection and signal processing (Ye et al., 1999). During retinal aging, neuronal components of retina develop structural and functional changes that can adversely affect retinal function. Examples of age-dependent diseases of the retina include glaucoma and age-related macular degeneration (AMD), in which structural changes leading to visual loss develop in ganglion cells or outer retina, RPE, and choriocapillaris (Nag et al., 2006). The human macula, which is an anatomic region approximately 6 mm in diameter delineated by the optic nerve and the superior and inferior temporal vascular arcades, is adversely affected in AMD (Hornan et al., 2007). As a disease AMD is characterized by cellular changes in RPE, choriocapillaris, and outer retina and by structural changes in Bruch’s membrane (Del Priore and Tezel, 1998; Spraul et al., 1999). Cellular changes that occur in AMD include atrophy of the RPE, choriocapillaris, and outer retina in non-exudative AMD as well as the development of choroidal or intraretinal neovascularization in exudative AMD (Chader, 2002). Ultimately some changes in cellular behavior may be initiated by or reflected in alterations in the gene expression profile of the cells (Radeke et al., 2007; Chen et al., 2008; Kurji et al., 2009; Stadler and Come, 2009). A systematic comparison of the gene expression profiles of young vs. older neural retina is thus important, as analysis of the retinal transcriptome may allow us to define a role for some genes in either initiating or responding to the cellular changes that occur in age-dependent diseases such as AMD. Topographic location may also affect gene expression profiling, since some diseases such as AMD affect the macula and periphery differently (van Soest et al., 2007).

To this end we have compared the gene expression profiles of young vs. old human neural retina, using both macular and peripheral neural retinal explants. In essence, macular and peripheral neural retinas were harvested from young and older human donor eyes and the retinal gene expression profiles were determined using the Affymetrix DNA microarray chip U133 plus 2. We were able to test the expression profile of 54,600 gene probes and determine genes whose expression level (mRNA) was altered by temporal (young vs. older) or spatial (macular vs. peripheral) factors. Knowledge of the function of genes with an altered expression profile may provide insight into the role of age-related changes in gene expression in the pathogenesis of human ocular disease.

 Materials and Methods Preparation of adult human retinal tissues

Twelve human donor eyes without recorded eye disease history from the National Disease Research Interchange (NDRI, Philadelphia, PA, USA) ranged in donor age from 18 to 79 years. Eyes were separated into a younger (18, 21, 32, 32, 35, and 43-year-old cadaver donors) and older (72, 74, 74, 74, 75, and 79-year-old cadaver donors) age group. All donor eyes were enucleated within 10 h of death and processed in the lab within 32 h of death (Table 1). Since the study involved postmortem tissue without identification of individual patients it was exempt from Institutional Review Board (IRB) approval. Upon receipt in the laboratory, eyes were cleaned of extraocular tissue. The eyes were placed in carbon dioxide-free media (Gibco, Grand Island, NY, USA) and an incision was made through the sclera 3 mm posterior to the limbus and extended circumferentially. Four radial incisions were then made through the sclera and the sclera was peeled away. A full-thickness circumferential incision was made 1 mm posterior to the ora serrata; the anterior segment; and vitreous were removed and discarded. The posterior pole of each eyecup was inspected visually with direct and retroillumination under a dissecting microscope and globes were discarded if there was any evidence of subretinal blood, extensive drusen, or irregular pigmentation of the macular RPE. The choroid-Bruch’s membrane-RPE complex was removed after trimming its attachment to the optic nerve using forceps, leaving the intact human retina as a flat mount. After rinsing three times with cold Dulbecco’s Phosphate Buffered Saline (PBS) the macular retina was isolated from each eye using a 5-mm circular punch; a 5 mm punch of peripheral retina was then obtained by trephination of a circular region whose posterior border was at least 10 mm away from the macular punch. Cut tissues were rinsed again and stored at −80°C prior to isolating RNA. Twelve pairs of eyes from human donors were independently (not pooled samples) used for DNA microarray study; given the expense and availability of human tissue, similar small sample sizes have been used in the past to generate important data on gene expression in human tissue (Wistow et al., 2002; Chowers et al., 2003; Hollborn et al., 2005). Four additional retinal explants (donor age 34, 38, 78, and 81), independent of the samples used in the DNA microarray studies, were also harvested for confirmatory qRT-PCR (quantitative reverse transcriptase polymerase chain reaction) using independent samples (not pooled, Table 1).

Human retina donor information.

Tissue ID Death-to-enucleation time (h) Enucleation to retina extraction time (h) Age (year-old) Gender and races Cause of death
FOR DNA MICROARRAY STUDY
Sample 1 7 11 18 CM Trauma
Sample 2 10 20 21 CM Breast cancer
Sample 3 3 26 32 CM Motor vehicle accident
Sample 4 2 29 32 CF Seizures
Sample 5 6 16 35 CM Cerebrovascular accident
Sample 6 10 18 43 CF Motor vehicle accident
Sample 7 8.5 23 72 CM Head trauma
Sample 8 2 21 74 CM Cardiac arrest
Sample 9 6.5 14 74 CF Breast cancer
Sample 10 10 10 74 CM Lung cancer
Sample 11 4 20 75 CM Anoxic encephalopathy
Sample 12 3.5 12 79 CF Respiratory failure
FOR RT-PCR
Sample 13 7 10 34 CM Head trauma
Sample 14 13.5 10 38 CM Unknown
Sample 15 7 23 78 BM Cardiac arrest
Sample 16 5 10 81 CM colon cancer

Human retina donor information for microarray and real time qRT-PCR. All donor eyes were enucleated within 10 h of death and subsequently shipped to the lab within 32 h of death. All samples passed quality control using the hybridization signals from 3′, middle, and 5′ fragment of mRNA of housekeeping genes coded in the Affymetrix DNA chips (see Figure 1), suggesting that there is reasonable stability of RNA isolated from cadaver human donor eyes. C, Caucasian; B, black; M, male; F, female.

 Isolation of total RNA

Human macula and peripheral retina were taken from a −80°C freezer and total RNA was isolated and purified using a Qiagen RNeasy Mini Kit according to manufacturer’s instructions as described previously (Cai and Del Priore, 2006; Gong et al., 2008). Briefly, retinal tissue was disrupted and 600 μl of lysing buffer (RLT) was added to cells in a 1.5-ml microfuge tube. The cell lysate was loaded onto a QIAshredder spin column and spun for 2 min at 13,000 rpm. The homogenized lysate was then mixed with 600 μl of 70% ethanol and applied to an RNeasy mini spin column and centrifuged for 15 s at 13,000 rpm. The specimen was then washed twice by adding 700 μl of Buffer RW1 and Buffer RPE, with subsequent spinning. Sixty microliters RNase-free water was used to elute total RNA from an RNeasy column. Approximately 8 μg of total RNA were extracted from macular and peripheral tissues (one punch each) of one pair of donor eyes. The quality of total RNA was assessed with the RNA denaturing agarose gel electrophoresis and microarray assay (see below).

 DNA microarray experiments

A T7-(dT)24 oligomer, superscript reverse transcriptase II and DNA Polymerase I (Gibco BRL) were used for first-strand and second-strand cDNA synthesis using 5 μg of total RNA as templates for each sample. Double-stranded cDNA was cleaned with Phase Lock Gels-Phenol/Chloroform extraction and ethanol precipitation. Biotin-labeled antisense cRNA was produced by an in vitro transcription reaction (ENZO BioArray High Yield RNA Transcript Labeling Kit) and incubated with fragmentation buffer (Tris-acetate, KOAc and MgOAc) at 94°C for 35 min. Target hybridization, washing, staining, and scanning probe arrays were done following an Affymetrix GeneChip Expression Analysis Manual. All human retinal samples are processed with individual microarray chips independently. The data then averaged/pooled for analysis and compared (MIAME accession # GSE32614).

 Quality controls, definitions of gene presence or absence and statistical analysis

For assessing the quality of retinal RNA, 1% agarose gel with 0.22 M formaldehyde was used for RNA electrophoresis. One microgram of total RNA isolated from peripheral retinal samples was mixed with 2× loading buffer (Fisher Scientific) and run with 1× MOPS [3-(N-morpholino)propanesulfonic acid] buffer (Fisher Scientific). After ethidium bromide staining RNA bands were visualized with a UV transilluminator and 28S and 18S rRNA band patterns were analyzed.

For quality control the U133 plus 2 DNA microarray chips (Affymetrix, Santa Clara, CA, USA) used include housekeeping gene probes to measure the consistency of the hybridization signals from their 3′, middle, and 5′ fragment of these mRNA coding regions (Hubbell et al., 2002). Gene expression analyses, including global normalization, scaling, and Gene Ontology analysis were performed using the Affymetrix Expression Console (Ver. 1.1.) and GeneSifter Genetic Analysis system (Geospiza, Inc., Seattle, WA, USA). For the purpose of this study, gene expression was labeled as being differentially expressed if they were detected as present in the samples compared (i.e., young vs. old or macula vs. peripheral retina), had expression levels >50 in densitometry, and there was at least 2.0-fold difference in expression level that was statistically significant (p < 0.05 with Benjamini and Hochberg adjusted Student’s t-test; Benjamini et al., 2001). We calculated a z-score to determine the relative gene expression changes (Doniger et al., 2003) and thereby identify biological processes, cellular components, and molecular group functions of those genes that warrant further study (Ashburner et al., 2000).

 Real time quantitative RT-PCR

Real time Quantitative RT-PCR (qRT-PCR) was performed on retinal samples harvested from different donors (ages 34, 38, 78, and 81 years) than those used to generate the microarray data (Table 1). The LightCycler system (Roche Diagnostics Corp.) was used for real time quantitative RT-PCR. An RNA Amplification Kit SYBR Green I (Roche Molecular Biochemicals, Mannheim, Germany) was used to synthesize the first-strand cDNA and subsequent amplification using gene specific primers (Table 2). The PCR reaction solution contains 0.5 μg of total RNA, 6 mM MgCl2, and 0.5 μM of each primer. Other components in qRT-PCR master mix contain buffer, enzyme, SYBR green and dNTP. For reverse-transcription, reaction capillaries containing 20 μl RT-PCR reaction mix were incubated at 55°C for 10 min, followed by incubation at 95°C for 30 s. qRT-PCR was performed using an initial denaturation for 1 s at 95°C, followed by 35 cycles of denaturation for 1 s at 95°C, annealing for 10 s at 55°C, and extension for 13 s at 72°C in a programmable LightCycler. A melting curve analysis was performed by following the final cycle with incubation at 95°C for 1 s, 65°C for 10 s, followed by a temperature transition rate of 20°C/s to reach 95°C. Negative controls for the qRT-PCR analysis, which contained all reaction components except for RNA, were performed simultaneously to determine when the non-specific exponential amplification cycle number was reached.

Primers used and the result of semi-quantitative RT-PCR compared to DNA microarray.

Gene Name Gene Symbol Oligo sequence Fold changes
 Tissue compared
Microarray RT-PCR
Protein tyrosine kinase-2 PTK2 Fwd-GCCTATTAAATGGATGGCTCCAG 2.9 2.3 Young/old macula
Rev-AATTCGACCGATTACATCATTGTTCT
Brain-derived neurotrophic factor BDNF Fwd-AAGATACATTTGTATGTTGTGAAGATGTTT 2.5 4.9 Young/old macula
Rev-GCTTACTCTGACCAACGCC
XIAP associated factor-1 XAF1 Fwd-CGAGCAGGGTTTCTTTATACTGG 2.3 2.5 Young/old macula
Rev-TGTAGACTGCGTGGCACT
Cadherin 8, type 2 CDH8 Fwd-CTACTGAAATTAGGAACCACAGTCAGAT 2.2 3.0 Young/old macula
Rev-CTAACAGTTTGAATGACTTGGCCG
Chloride intracellular channel 4 CLIC4 Fwd-CTGAATCACTTAAGAATTTCAGAATACCCT 3.0 2.5 Old/young macula
Rev-ACCATGATTTATTGGGAGATGTTTATGTC
Nuclear receptor co-repressor 2 NCOR2 Fwd-GGGCCACGTCATCTACGA 2.6 3.3 Old/young macula
Rev-CTCCATCATGTCATAGGTGCG
Dickkopf homolog 1 DKK1 Fwd-GGAATCCTGTACCCGGGC 6.6 2.4 Periphery/macula (all ages)
Rev-CTGCAGGCGAGACAGATTTG
Secreted frizzled-related protein 2 SFRP2 Fwd-GGAGATAACCTACATCAACCGAGATAC 5.7 2.1 Periphery/macula (all ages)
Rev-GTCCCATGACCAGATAGGGC
Frizzled homolog 10 FZD10 Fwd-CCGGCTTCGTGCTCATT 3.0 2.2 Periphery/macula (all ages)
Rev-CAGCACAGAGAAGAGCCCGATA

Genes and corresponding oligonucleotide primers used for selective real time polymerase chain reaction (qRT-PCR). The last two columns show the ratio of mRNA expression levels from DNA microarray or qRT-PCR studies. Changes in expression are always in the same directions for qRT-PCR compared to microarray data, although the magnitude of the change can vary.

 Results Sample quality control assessment

To determine the quality of the RNA isolated from human eyes, we determined the ratio of the 28S and 18S bands in the isolated RNA. The intensity ratio of 28S/18S was approximately 2.0: 1 without any significant smearing of the leading edges of either band (Data not shown). In addition a quality control analysis was performed using the hybridization signals from 3′, middle, and 5′ fragment of mRNA of endogenous housekeeping genes and exogenous “spiking” genes coded in the Affymetrix DNA chips (Hubbell et al., 2002; Archer and Guennel, 2006). All 24 samples passed the pre-established quality control criteria, which was detection of signal from each of the control genes (Figure 1). To exclude any potential bias due to differences in handling of young vs. older tissue, we demonstrated that there was no correlation between donor age and death-to-enucleation time (Figure 2A) or death-to-RNA-extraction time (Figure 2B). In addition, there was no correlation between the 3′/5′ ratio for the housekeeping gene GADPH and the death-to-RNA-extraction time (Figure 3).

Ratio of the 3′ and 5′ signal obtained from human house keeping gene GAPDH using microarray. Study was performed to assess mRNA quality isolated from human donor eyes. Young samples and older samples are presented in order of donor age for both macular and peripheral samples. There is no correlation between donor age and signal ratio. The average of 3′/5′ signal ratio of all samples is 1.152 ± 0.07, which denotes good quality.

Human retina donor information. (A) Human Retina Donor Age vs. Death-To-Enucleation Time (B). Human Donor Age vs. Death-to-RNA-Extraction Time. Data showed that no bias was introduced by handling younger and older tissue differently, as there is no correlation between donor age and either death-to-enucleation or death-to-RNA isolation time.

Death-to-RNA-Extraction time vs. GAPDH 3′/5′ ratio in macular tissue. Data shows no correlation between enucleation time and the quality of RNA (the closer the ratio is to 1, the better the RNA quality) within the 31.5 h death-to-RNA-extraction time.

 Global and hierarchical clustering analysis

We detected the expression of approximately 26,700 gene probes out of 54,600 gene probes present on the Affymetrix Human Genome U133 plus 2 chip. There was no statistically significant difference in the total number of genes expressed between human young macula (26686 ± 319), old macula (26956 ± 275), young peripheral retina (27122 ± 108), or old peripheral retina (26533 ± 490; data not shown). There was also no statistically significant difference in the standard deviations of the number of genes expressed among these four groups (F-test, p > 0.05). Hierarchical clustering analysis of 24 samples showed that the transcriptome of the older macula and peripheral retina cluster together and young macula and peripheral retina cluster together as well (Figure 4), suggesting that there is a significant effect of aging on the gene expression profile of the human neural retina.

Hierarchical clustering analysis of retinal samples shows old and young retina (macular and peripheral) cluster separately, suggesting that aging changes the expression profile more than location (macula vs. periphery). Young macular and peripheral samples were from different individuals for this analysis. Likewise older macular and peripheral samples were from different individual donors.

 Gene expression analysis

There are 81 genes among approximately 26,700 gene probes that are expressed at higher levels (Table 3) in macula compared to peripheral retinal samples (combining all age groups) using the definition described above. These genes have a wide array of functions, including lipid metabolism, ion transport, neuronal differentiation and regulation of transcription, cell adhesion and motility, and differentiation. There are 24 genes expressed at higher levels (Table 4) in the peripheral vs. macular retina (combining all age groups). These genes include those that are involved in the Wnt receptor signaling pathway, including DKK1 (Dickkopf homolog 1), FZD10 (frizzled homolog), and SFRP2 (secreted frizzled-related protein; Table 4; Robitaille et al., 2002; Kubo et al., 2003; Liu et al., 2007).

Genes highly expressed (up-regulated) in macula compared to peripheral retina.

Gene title Gene Symbol GO biological process term Gene expression fold-change p-Value
Peripherin PRPH Intermediate filament cytoskeleton organization 8.3 2.45E−11
POU class 4 homeobox 2 POU4F2 Negative regulation of transcription from RNA polymerase II promoter 7.86 8.10E−12
Serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 2 SERPINE2 Nervous system development 6.87 8.73E−10
Transmembrane protein 163 TMEM163 Integral to membrane 6.72 1.02E−10
Popeye domain containing 3 POPDC3 Integral to membrane 6.54 4.22E−14
AHNAK nucleoprotein 2 AHNAK2 Keratinization; cell differentiation 6.33 1.86E−12
POU class 4 homeobox 1 POU4F1 Nervous system development; axonogenesis; synaptogenesis 6.03 1.10E−10
Iroquois homeobox 2 IRX2 Regulation of transcription; transcription factor activity 6.01 4.26E−13
Sodium channel, voltage-gated, type I, beta SCN1B Ion transport 5.81 7.36E−13
Neurofilament, heavy polypeptide 200 kDa NEFH Nervous system development 5.66 2.48E−11
Early B-cell factor-1 EBF1 Regulation of transcription 5.54 6.66E−12
Annexin A2 ANXA2 Skeletal development 5.51 3.93E−15
Regulator of G-protein signaling 7 binding protein RGS7BP Negative regulation of signal transduction 5.32 2.53E−06
Fatty acid binding protein 3, muscle, and heart (mammary-derived growth inhibitor) FABP3 Negative regulation of cell proliferation 5.25 4.97E−10
Male sterility domain containing 1 FAR2 Lipid biosynthetic process; oxidation reduction 5.15 2.07E−09
Microtubule-associated protein 1A MAP1A Sensory perception of sound 5.05 6.92E−10
Peripheral myelin protein 2 PMP2 Establishment of localization; lipid binding 4.93 3.04E−05
Sushi-repeat-containing protein, X-linked SRPX Cell adhesion 4.87 1.81E−08
Iroquois homeobox 1 IRX1 Regulation of transcription 4.76 4.48E−09
Neurofilament, light polypeptide 68 kDa NEFL Neurofilament bundle assembly 4.69 2.43E−11
Sulfotransferase family 4A, member 1 SULT4A1 Lipid metabolic process 4.65 2.13E−08
Low density lipoprotein receptor (familial hypercholesterolemia) LDLR Lipid metabolic process 4.58 7.77E−10
Visinin-like 1 VSNL1 Neuronal calcium sensor 4.38 6.37E−08
RAB37, member RAS oncogene family RAB37 Protein transport 4.32 8.19E−07
24-Dehydrocholesterol reductase DHCR24 Anti-apoptosis; response to oxidative stress; neuroprotection 4.27 1.63E−10
Complexin 1 CPLX1 Neurotransmitter transport; synaptic transmission 4.23 1.38E−09
ELAV (embryonic lethal, abnormal vision, Drosophila)-like 4 (Hu antigen D) ELAVL4 Cellular macromolecule metabolic process 4.15 1.22E−08
Sodium channel, voltage-gated, type IV, beta SCN4B Ion transport 3.81 2.66E−12
Cholinergic receptor, nicotinic, beta-3 CHRNB3 Signal transduction 3.76 2.57E−08
Adenylate cyclase 3 ADCY3 Intracellular signaling cascade; response to stimulus 3.75 6.55E−11
Multiple C2 domains, transmembrane 1 MCTP1 Calcium-mediated signal transduction 3.72 5.52E−07
RNA binding protein with multiple splicing 2 RBPMS2 Nucleotide binding 3.72 1.98E−11
Leucine rich repeat containing 8 family, member C LRRC8C Protein binding; integral to membrane 3.68 1.28E−09
Microtubule-associated monooxygenase, calponin, and LIM domain containing 2 MICAL2 Electron transport 3.62 5.36E−10
RNA binding protein with multiple splicing RBPMS RNA processing; nucleic acid binding 3.58 2.10E−12
Ras-like without CAAX 2 RIT2 Synaptic transmission 3.5 4.66E−10
GNAS complex locus GNAS Protein targeting; signal transduction 3.46 7.02E−08
Growth associated protein 43 GAP43 Nervous system development; cell differentiation 3.35 1.44E−05
Trophoblast glycoprotein TPBG Cell motility; cell adhesion 3.32 5.90E−06
Brain expressed, associated with Nedd4 BEAN Protein binding; integral to membrane 3.29 1.53E−10
Sodium channel, voltage-gated, type I, alpha subunit SCN1A Ion transport 3.28 3.83E−07
Methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2, methenyltetrahydrofolate cyclohydrolase MTHFD2 One-carbon compound metabolic process 3.28 2.33E−04
Ectonucleoside triphosphate diphosphohydrolase 3 ENTPD3 Nucleoside diphosphate catabolic process 3.22 4.16E−05
Potassium intermediate/small conductance calcium-activated channel, subfamily N, member 2 KCNN2 Ion transport 3.21 1.06E−09
EPH receptor A4 EPHA4 Signal transduction; axon guidance 3.1 7.37E−07
ELAV (embryonic lethal, abnormal vision, Drosophila)-like 2 (Hu antigen B) ELAVL2 Regulation of transcription, DNA-dependent 3.09 3.05E−08
Eukaryotic translation initiation factor 5A2 EIF5A2 Translational initiation; polyamine homeostasis 3.04 1.11E−10
KISS1 receptor KISS1R Negative regulation of cell proliferation 3.04 5.44E−08
Leucine rich repeat and fibronectin type III domain containing 5 LRFN5 Intracellular membrane-bounded organelle 3.02 1.63E−06
Deleted in liver cancer 1 DLC1 Regulation of cell adhesion 2.98 2.08E−11
Neuritin 1 NRN1 Axonal regeneration; experimental diabetic neuropathy 2.94 6.76E−11
Solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 6 SLC17A6 Transport 2.94 7.92E−11
Synuclein, gamma (breast cancer-specific protein 1) SNCG Intracellular non-membrane-bounded organelle 2.94 2.66E−08
L1 cell adhesion molecule L1CAM Cell adhesion; nervous system development 2.92 3.78E−11
HIV-1 Tat interactive protein 2, 30 kDa HTATIP2 Regulation of apoptosis; regulation of angiogenesis 2.9 7.43E−09
Myocardial infarction associated transcript (non-protein coding) MIAT Associated with myocardial infarction 2.9 1.88E−07
Ankyrin 1, erythrocytic ANK1 Exocytosis; maintenance of epithelial cell polarity 2.89 4.38E−08
Synaptic vesicle glycoprotein 2C SV2C Neurotransmitter transport 2.83 5.85E−10
Eomesodermin homolog (Xenopus laevis) EOMES Anatomical structure morphogenesis; cell differentiation 2.82 2.06E−09
Heparan sulfate 6-O-sulfotransferase 3 HS6ST3 Transferase activity; integral to membrane 2.73 3.05E−10
Collagen, type IV, alpha 4 COL4A4 Long-term strengthening of neuromuscular junction 2.71 3.25E−10
Thy-1 cell surface antigen THY-1 Angiogenesis; retinal cone cell development; focal adhesion 2.7 2.88E−10
Cholinergic receptor, nicotinic, alpha 6 CHRNA6 Synaptic transmission 2.68 7.26E−10
Stearoyl-CoA desaturase (delta-9-desaturase) SCD Lipid metabolic process; iron ion binding 2.66 2.77E−09
Lanosterol synthase (2,3-oxidosqualene-lanosterol cyclase) LSS Lipid biosynthetic process 2.63 6.13E−10
Neurofilament, medium polypeptide 150 kDa NEFM Intermediate filament cytoskeleton organization and biogenesis 2.63 2.85E−12
Contactin 2 (axonal) CNTN2 Neuron migration; cell adhesion; integral to plasma membrane 2.57 1.24E−08
Vesicle-associated membrane protein 1 (synaptobrevin 1) VAMP1 Vesicle-mediated transport 2.53 1.19E−12
Hypothetical protein FLJ33996 FLJ33996 EST sequence; function known 2.52 3.82E−09
Lipin 1 LPIN1 Required for normal adipose tissue development 2.43 3.08E−03
Thyroid hormone responsive (SPOT14 homolog, rat) THRSP Regulation of transcription; lipid metabolic process 2.29 1.09E−09
Calsyntenin 2 CLSTN2 Cell adhesion; calcium ion binding; postsynaptic membrane 2.25 7.39E−08
Stathmin-like 2 STMN2 Intracellular signaling cascade; neuron differentiation 2.2 2.10E−11
Early B-cell factor 3 EBF3 Regulation of transcription 2.18 1.42E−05
Glutaredoxin (thioltransferase) GLRX Electron transport 2.16 4.73E−09
SLIT-ROBO Rho GTPase activating protein 2 SRGAP2 GTPase activator activity 2.15 3.63E−07
Nicotinamide nucleotide adenylyltransferase 2 NMNAT2 NAD biosynthetic process; nucleotidyltransferase activity 2.13 1.89E−07
Protein phosphatase 2 (formerly 2A), regulatory subunit B, gamma isoform PPP2R2C Signal transduction 2.09 3.15E−09
Histone deacetylase 9 HDAC9 Regulation of transcription, DNA-dependent 2.07 1.33E−07
RAB15, member RAS oncogene family RAB15 Small GTPase mediated signal transduction; GTP binding 2.04 5.61E−08
Kinesin family member 5A KIF5A Microtubule-based movement; ATP-binding 2.03 2.21E−07

Genes highly expressed (up-regulated) in macular compared to peripheral retina (all ages). For changes in gene expression level we used a cutoff of >2.0-fold higher expression level in macular vs. peripheral retina (p < 0.05, Benjamini and Hochberg adjusted Student’s t-test; expression level >50 on densitometry). These genes have a wide array of functions, including lipid metabolism, ion transport, neuronal differentiation and regulation of transcription, cell adhesion and motility, and differentiation.

Genes highly expressed in peripheral compared to macular retina.

Gene title Gene symbol GO biological process term Periphery vs. macula (all ages) gene expression fold-change p-Value
Forkhead box G1 FOXG1 Regulation of transcription 7.1 5.21E−14
Dickkopf homolog 1 (Xenopus laevis) DKK1 Wnt receptor signaling pathway 6.59 3.44E−05
Secreted frizzled-related protein 2 SFRP2 Wnt receptor signaling pathway 5.69 6.70E−08
Hydroxysteroid (17-beta) dehydrogenase 2 HSD17B2 Lipid biosynthetic process 5.08 9.67E−09
Collagen, type II, alpha-1 (primary osteoarthritis, spondyloepiphyseal dysplasia, congenital) COL2A1 Phosphate transport 4.54 4.42E−08
Zic family member 1 (odd-paired homolog, Drosophila) ZIC1 Nervous system development 3.68 2.40E−07
Frizzled homolog 10 (Drosophila) FZD10 Wnt receptor signaling pathway 2.96 2.12E−07
Inhibitor of DNA binding 3, dominant negative helix-loop-helix protein ID3 Negative regulation of transcription 2.75 4.49E−04
LIM homeobox 9 LHX9 Regulation of transcription, DNA-dependent 2.69 1.21E−09
Potassium inwardly rectifying channel, subfamily J, member 13 KCNJ13 Ion transport 2.68 5.79E−05
Histone cluster 2, H2aa3 HIST2H2AA3 Nucleosome assembly 2.64 6.86E−04
Zic family member 2 (odd-paired homolog, Drosophila) ZIC2 Multicellular organismal development 2.53 1.70E−07
Histone cluster 1, H2bb HIST1H2BB Nucleosome assembly 2.52 3.43E−03
Myoneurin MYNN Regulation of transcription, DNA-dependent 2.48 1.51E−06
Protein phosphatase 1, regulatory (inhibitor) subunit 3C PPP1R3C Carbohydrate metabolic process 2.44 9.18E−06
STEAP family member 4 STEAP4 Ion transport 2.44 1.81E−06
Histone cluster 1, H2bc HIST1H2BC Nucleosome assembly 2.43 2.41E−03
ATPase, Na+/K+ transporting, alpha 2 (+) polypeptide ATP1A2 ATP biosynthetic process 2.28 8.95E−06
FXYD domain containing ion transport regulator 6 FXYD6 Ion transport 2.28 6.45E−07
Cysteine and glycine-rich protein 2 CSRP2 Multicellular organismal development 2.26 6.46E−08
Tigger transposable element derived 2 TIGD2 Cellular biopolymer biosynthetic process 2.13 2.34E−05
Nuclear receptor subfamily 4, group A, member 2 NR4A2 Nervous system development 2.12 9.61E−03
Rhodopsin RHO Rhodopsin mediated signaling pathway 2.05 4.17E−05
Histone cluster 1, H4b HIST1H4B Phosphoinositide-mediated signaling 2.01 6.47E−03

Genes highly expressed in peripheral compared to macular retina (all ages). For changes in gene expression level we used a cutoff of >2.0-fold higher expression level in peripheral vs. macular retina (p < 0.05, Benjamini and Hochberg adjusted Student’s t-test; expression level >50 on densitometry). Note that DKK1, FZD10, and SFRP2 are expressed at higher levels in the peripheral retina than macular retina, suggesting that there is inhibition of the Wnt signaling pathway in the periphery compared to the human macula.

Aging alters the expression profile of numerous genes within the human macula. There are 85 genes that were expressed at higher levels (Table 5) in young macula compared to older macula. This includes genes with a diverse range of functions, including cell metabolism, cell regulation, development, and other cellular processes (Figure 5A). There are 55 genes that were expressed at higher levels (Table 6) in older compared to younger human macula. This includes genes with a wide role in cell proliferation, survival, and differentiation (Figure 5B).

Gene ontology of biological processes (high z-score) involved with genes. (A) Up-regulated; (B) down-regulated in young macula compared with older macula; (C) up-regulated; (D) down-regulated in young compared with older peripheral retina. Note that genes involved with “growth” are only shown in young macula and peripheral retina but missing in older macula and periphery.

Genes highly expressed in young compared to old macular retina.

Gene title Gene symbol GO biological process term Young vs. older macula gene expression fold-change p-Value
Chitinase 3-like 1 (cartilage glycoprotein-39) CHI3L1 Carbohydrate metabolic process 9.26 1.80E−04
Peripheral myelin protein 2 PMP2 Transport; lipid binding 5.31 6.88E−04
Interferon-induced protein with tetratricopeptide repeats 3 IFIT3 Receptor binding 3.86 1.96E−02
Fatty acid binding protein 5 (psoriasis-associated) FABP5 Lipid metabolic process 3.82 5.56E−04
Autocrine motility factor receptor AMFR Ubiquitin cycle; signal transduction 3.76 3.47E−08
Chemokine (C-X-C motif) ligand 2 CXCL2 Inflammatory response; G-protein-coupled signaling pathway 3.43 4.36E−03
Serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1) SERPINE1 TGF-beta signaling pathway; regulation of angiogenesis 3.43 9.28E−03
Cytoplasm; intracellular part IFI44L Interferon-induced protein 44-like 3.27 8.04E−04
Matrix Gla protein MGP Cartilage condensation; cell differentiation m ion 3.19 4.62E−03
Defensin, beta 119 DEFB119 Defense response 3.05 2.68E−02
Immune response GBP1 Guanylate binding protein 3 3.04 7.91E−04
metabolic process MICAL2 Microtubule-associated monooxygenase, calponin, and LIM domain containing 2 2.99 7.62E−03
Nucleoside diphosphate catabolic process ENTPD3 Ectonucleoside triphosphate diphosphohydrolase 3 2.98 4.88E−03
Regulation of transcription, DNA-dependent BACH2 BTB and CNC homology 1, basic leucine zipper transcription factor 2 2.96 5.92E−05
Angiogenesis ELK3 ELK3, ETS-domain protein (SRF accessory protein 2) 2.96 2.81E−02
Cell-substrate junction assembly ITGA6 Integrin, alpha 6 2.95 4.23E−02
Protein binding SNCG Synuclein, gamma (breast cancer-specific protein 1) 2.94 2.45E−06
Regulation of ARF protein signal transduction PSD3 Pleckstrin and Sec7 domain containing 3 2.93 3.15E−03
Regulation of transcription, DNA-dependent STAT1 Signal transducer and activator of transcription 1, 91 kDa 2.93 2.52E−04
Positive regulation of cell proliferation TIMP1 TIMP metallopeptidase inhibitor 1 2.93 2.31E−03
ATP biosynthetic process ATP2B3 ATPase, Ca++ transporting, plasma membrane 3 2.92 5.38E−03
Ubiquitin-dependent protein catabolic process PSMB9 Proteasome (prosome, macropain) subunit, beta type, 9 (large multifunctional peptidase 2) 2.92 5.17E−03
Extracellular region CCDC80 Coiled-coil domain containing 80 2.91 7.56E−04
Multicellular organismal development ELAVL3 ELAV (embryonic lethal, abnormal vision, Drosophila)-like 3 (Hu antigen C) 2.91 7.25E−04
Regulation of transcription, DNA-dependent NHLH2 Nescient helix-loop-helix 2 2.91 3.08E−03
Glutamate decarboxylation to succinate GAD1 Glutamate decarboxylase 1 (brain, 67 kDa) 2.9 1.15E−02
Suckling behavior POU4F1 POU class 4 homeobox 1 2.9 2.46E−03
Protein tyrosine kinase-2 PTK2 Neuron migration; cell motility; integrin-mediated signaling pathway 2.9 7.78E−12
Protein modification process PCMTD2 Protein-l-isoaspartate (d-aspartate) O-methyltransferase domain containing 2 2.89 6.55E−03
Ion transport SCN2B Sodium channel, voltage-gated, type II, beta 2.89 9.94E−03
Ion transport KCNQ2 Potassium voltage-gated channel, KQT-like subfamily, member 2 2.88 1.21E−03
Structural molecule activity MAP1A Microtubule-associated protein 1A 2.88 5.96E−06
Multicellular organismal development EMP1 Epithelial membrane protein 1 2.8 1.14E−02
Vitronectin VTN Inflammatory response pathway; cell adhesion 2.7 1.42E−03
Cell adhesion TPBG Trophoblast glycoprotein 2.64 6.54E−03
CART prepropeptide CARTPT neuropeptide signaling pathway; transmission of nerve impulse 2.62 7.06E−03
One-carbon compound metabolic process MTHFD2 Methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2, methenyltetrahydrofolate cyclohydrolase 2.62 2.81E−02
Golgi associated PDZ and coiled-coil motif-containing GOPC ER to Golgi vesicle-mediated transport; Golgi to plasma membrane transport 2.6 9.99E−04
Chromosome 8 open reading frame 4 C8orf4 Apoptosis 2.57 1.79E−02
Tumor necrosis factor receptor superfamily, member 12A TNFRSF12A Angiogenesis; apoptosis; cell motility 2.53 4.51E−04
Brain-derived neurotrophic factor BDNF Positive regulation of neuron differentiation; anti-retinal programmed cell death 2.51 2.19E−03
Protein phosphatase 2 (formerly 2A), regulatory subunit B, gamma isoform PPP2R2C Signal transduction; protein phosphatase type 2A regulator activity 2.51 3.18E−07
Solute carrier family 1 (neuronal/epithelial glutamate transport) SLC1A1 Transport; dicarboxylic acid transport; synaptic transmission 2.49 2.79E−03
Mitogen-activated protein kinase kinase kinase 14 MAP3K14 Protein amino acid phosphorylation 2.47 5.84E−06
Signal transduction GNG4 Guanine nucleotide binding protein (G-protein), gamma 4 2.46 5.07E−03
Paraneoplastic antigen MA2 PNMA2 Transport 2.46 2.38E−04
Thyrotropin-releasing hormone TRH Cell-cell signaling; hormone-mediated signaling 2.44 1.08E−03
mRNA catabolic process HSPA1B Heat shock 70 kDa protein 1B 2.4 2.95E−02
Selenocysteine incorporation DIO2 Deiodinase, iodothyronine, type II 2.39 9.55E−03
Cell surface receptor linked signal transduction IFITM1 Interferon-induced transmembrane protein 1 (9–27) 2.39 7.94E−04
Interleukin 8 IL8 Angiogenesis; cell motility; chemotaxis 2.39 1.33E−02
Myxovirus (influenza virus) resistance 1, interferon-inducible protein p78 (mouse) MX1 Induction of apoptosis; defense response 2.38 1.17E−02
Regulation of cell growth TMEM97 Transmembrane protein 97 2.38 1.09E−03
Cas-Br-M (murine) ecotropic retroviral transforming sequence CBL Cell surface receptor linked signal transduction 2.37 1.28E−02
Type I interferon biosynthetic process IRF9 Interferon regulatory factor 9 2.36 1.71E−04
Dihydropyrimidinase-like 2 DPYSL2 Nucleobase, nucleoside, nucleotide, and nucleic acid metabolism 2.35 1.17E−03
p21 (CDKN1A)-activated kinase 6 PAK6 Protein amino acid phosphorylation 2.34 4.12E−05
Zinc finger protein 441 ZNF441 Transcription; regulation of transcription, DNA-dependent 2.32 5.24E−04
Ubiquitin specific peptidase 31 USP31 Ubiquitin-dependent protein catabolism; ubiquitin cycle 2.29 3.81E−03
Transmembrane 4 L six family member 1 TM4SF1 Integral to plasma membrane 2.28 5.72E−03
Protein binding DTX3L Deltex 3-like (Drosophila) 2.26 1.66E−02
Response to stress HSPA1A Heat shock 70 kDa protein 1A 2.26 5.88E−03
Kruppel-like factor 7 (ubiquitous) KLF7 Transcription; regulation of transcription from RNA polymerase II promoter 2.26 2.42E−04
XIAP associated factor-1 XAF1 Apoptosis; negative regulation of cell cycle 2.26 3.94E−05
Pleckstrin homology domain containing, family G (with RhoGef domain) PLEKHG4 Cell death; regulation of Rho protein signal transduction 2.24 4.53E−04
Complement component 1, r subcomponent C1R Proteolysis; complement activation, classical pathway 2.21 5.17E−03
Cadherin 8, type 2 CDH8 Cell adhesion; homophilic cell adhesion; cell adhesion 2.2 2.40E−03
Regulation of cell growth GAP43 Growth associated protein 43 2.19 1.32E−03
Regulation of translational initiation HSPB1 Heat shock 27 kDa protein 1 2.18 4.51E−02
Keratinization AHNAK2 AHNAK nucleoprotein 2 2.17 1.04E−03
Regulation of cell growth CD44 CD44 molecule (Indian blood group) 2.16 4.18E−02
Regulation of neurotransmitter levels GABRA2 Gamma-aminobutyric acid (GABA) A receptor, alpha 2 2.14 5.48E−03
Regulation of cell growth SOCS3 Suppressor of cytokine signaling 3 2.12 1.09E−04
Protein import into nucleus, docking XPO1 Exportin 1 (CRM1 homolog, yeast) 2.1 9.11E−03
Proteolysis PAPPA Pregnancy-associated plasma protein A, pappalysin 1 2.09 7.73E−04
Apoptosis PRUNE2 Prune homolog 2 (Drosophila) 2.09 6.46E−04
Protein binding TRIM9 Tripartite motif-containing 9 2.09 9.77E−03
Intrinsic to membrane MYADM Myeloid-associated differentiation marker 2.08 6.84E−06
FOS-like antigen 2 FOSL2 Regulation of transcription from RNA polymerase II promoter; cell death 2.07 3.65E−02
Protein amino acid O-linked glycosylation LDLR Low density lipoprotein receptor (familial hypercholesterolemia) 2.07 1.68E−04
Cell adhesion FAT3 FAT tumor suppressor homolog 3 (Drosophila) 2.04 1.44E−02
Carbohydrate metabolic process FUT9 Fucosyltransferase 9 (alpha (1,3) fucosyltransferase) 2.04 3.84E−03
Regulation of transcription, DNA-dependent IRX1 Iroquois homeobox 1 2.02 1.78E−02
Histidine catabolic process MOXD1 Monooxygenase, DBH-like 1 2.01 4.51E−04
Response to unfolded protein HSPH1 Heat shock 105/110 kDa protein 1 2.00 1.73E−02

For changes in gene expression level we used a cutoff of >2.0-fold higher expression level in young vs. older macula (p < 0.05, Benjamini and Hochberg adjusted Student’s t-test; expression level >50 on densitometry). Note that the expression level of genes known to be important for retinal survival/protection such as X-linked inhibitor of apoptosis (XAF1), Cadherin (CDH8), PTK2 protein tyrosine kinase (PTK2), and brain-derived neurotrophic factor (BDNF) decrease in the aging retina.

Genes highly expressed in old compared to young macula.

Gene title Gene symbol GO biological process term Older vs. young macula gene expression fold-change p-Value
Dickkopf homolog 1 (Xenopus laevis) DKK1 Negative regulation of Wnt receptor signaling pathway 5.98 2.55E−10
G-protein-coupled receptor 177 GPR177 Positive regulation of I-kappaB kinase/NF-kappaB cascade 3.43 3.58E−03
Triadin TRDN Muscle contraction 3.35 2.05E−03
Synapse defective 1, Rho GTPase, homolog 2 (C. elegans) SYDE2 Signal transduction 3.24 2.24E−03
Ectonucleotide pyrophosphatase/phosphodiesterase 2 (autotaxin) ENPP2 Phosphate metabolic process 3.21 6.16E−05
Prolactin PRL Prostaglandin synthesis regulation; cell surface receptor linked signal transduction 3.18 3.93E−03
Solute carrier family 6 (neurotransmitter transporter, taurine), member 6 SLC6A6 Beta-alanine transport 3.11 9.26E−03
Potassium inwardly rectifying channel, subfamily J, member 13 KCNJ13 Potassium ion transport 3.09 3.37E−06
Epididymal sperm binding protein 1 ELSPBP1 Single fertilization 3.04 6.30E−03
Aquaporin 4 AQP4 Nervous system development 2.98 1.42E−05
Chloride intracellular channel 4 CLIC4 Negative regulation of cell migration; transport; chloride transport 2.98 8.59E−03
Rho GTPase activating protein 29 ARHGAP29 Rho protein signal transduction 2.95 1.98E−04
ATP-binding cassette, subfamily G (WHITE), member 1 ABCG1 Lipid transport 2.78 1.50E−04
Cerebellar degeneration-related protein 2, 62 kDa CDR2 Regulation of translation 2.74 4.51E−03
Cell division cycle 42 (GTP binding protein, 25 kDa) CDC42 Nuclear migration 2.66 9.55E−04
Cell division cycle associated 7 CDCA7 Transcription; regulation of transcription 2.66 1.05E−04
ADAM metallopeptidase with thrombospondin type 1 motif ADAMTS5 Proteolysis; protein amino acid prenylation; proteolysis 2.63 1.89E−04
Cyclin-dependent kinase inhibitor 3 CDKN3 Cell cycle; cell cycle arrest; negative regulation of cell proliferation 2.6 6.04E−05
Nuclear receptor co-repressor 2 NCOR2 Negative regulation of transcription, DNA-dependent 2.58 2.05E−05
Palmdelphin PALMD Regulation of cell shape 2.57 2.38E−03
5-Nucleotidase, ecto (CD73) NT5E DNA metabolic process 2.51 4.99E−03
Sarcospan (Kras oncogene-associated gene) SSPN Muscle contraction; cell adhesion 2.51 4.11E−05
Ras responsive element binding protein 1 RREB1 Ras protein signal transduction 2.45 3.41E−06
Zinc finger and BTB domain containing 1 ZBTB1 Transcription; regulation of transcription, DNA-dependent 2.41 8.92E−03
Lin-7 homolog C (C. elegans) LIN7C Neurotransmitter secretion 2.4 6.13E−05
Zic family member 1 (odd-paired homolog, Drosophila) ZIC1 Brain development 2.39 5.63E−04
Tetraspanin 2 TSPAN2 Cell motility; cell adhesion; cell proliferation 2.36 8.05E−03
Hydroxysteroid (17-beta) dehydrogenase 2 HSD17B2 Steroid biosynthetic process 2.35 5.87E−03
ATP-binding cassette, subfamily A (ABC1), member 4 ABCA4 Transport; visual perception; phototransduction, visible light 2.34 5.58E−03
Metallothionein 1F MT1F Copper ion binding 2.34 6.45E−03
ATPase, H+ transporting, lysosomal 56/58 kDa ATP6V1B1 Ossification; ion transport; sensory perception of sound 2.33 8.70E−03
Inhibitor of DNA binding 3, dominant negative helix-loop-helix protein ID3 Negative regulation of transcription from RNA polymerase II promoter 2.33 3.51E−02
UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7 B3GNT7 Protein amino acid glycosylation 2.32 2.01E−03
Solute carrier family 26 (sulfate transporter), member 2 SLC26A2 Inorganic anion transport 2.32 3.10E−08
Coiled-coil and C2 domain containing 1A CC2D1A Positive regulation of I-kappaB kinase/NF-kappaB cascade 2.31 1.88E−04
Growth arrest-specific 7 GAS7 Cell cycle arrest 2.31 1.57E−04
Leucine rich repeat containing 57 LRRC57 Protein binding 2.31 2.57E−04
Cholecystokinin CCK Neuron migration; axonogenesis; neuropeptide hormone activity 2.3 1.49E−04
Collagen, type II, alpha-1 COL2A1 Visual perception 2.3 5.61E−04
Cytochrome P450, family 26, subfamily B, polypeptide 1 CYP26B1 Cell fate determination; retinoic acid receptor signaling pathway 2.29 2.97E−07
Calsequestrin 1 (fast-twitch, skeletal muscle) CASQ1 Calcium ion binding 2.28 5.97E−03
Protein phosphatase 1, regulatory (inhibitor) subunit 3C PPP1R3C Carbohydrate metabolic process 2.27 2.43E−04
Chloride intracellular channel 5 CLIC5 Ion transport 2.26 2.25E−05
Matrix-remodeling associated 7 MXRA7 Integral to membrane 2.26 6.69E−04
Kelch-like 14 (Drosophila) KLHL14 Protein binding 2.25 6.75E−06
Phosphodiesterase 1A, calmodulin-dependent PDE1A Signal transduction; signal transduction 2.25 1.75E−03
Carboxylesterase 1 (monocyte/macrophage serine esterase 1) CES1 Metabolic process 2.24 3.28E−03
RAB23, member RAS oncogene family RAB23 Signal transduction; nervous system development 2.24 1.64E−02
Myeloid cell nuclear differentiation antigen MNDA Regulation of macromolecule metabolic process 2.22 5.92E−03
Family with sequence similarity 108, member B1 FAM108B1 Hydrolase activity 2.21 6.61E−03
Zinc finger, DBF-type containing 2 ZDBF2 Nucleic acid binding 2.21 3.18E−05
Tigger transposable element derived 4 TIGD4 Regulation of transcription 2.19 1.30E−03
2-Oxoglutarate and iron-dependent oxygenase domain containing 1 OGFOD1 Protein metabolic process 2.17 4.45E−03
Heterogeneous nuclear ribonucleoprotein F HNRNPF RNA splicing, via transesterification reactions 2.15 9.09E−03
Enolase 3 (beta, muscle) ENO3 Cellular macromolecule catabolic process 2.07 4.54E−03

Genes highly expressed in old compared to young macula retina. For changes in gene expression level we used a cutoff of >2.0-fold higher expression level in old vs. young macula (p < 0.05, Benjamini and Hochberg adjusted Student’s t-test; expression level >50 on densitometry). Note that aging increased the expression of genes related to aging and apoptosis, such as genes coding for the nuclear receptor co-repressor 2 (NCOR2) and chloride intracellular channel 4 (CLIC4).

There are 52 genes that were expressed at higher levels (Table 7) in younger peripheral vs. older peripheral retina. There are 34 genes that were expressed at higher levels (Table 8) in older vs. younger peripheral retina. The functions of these genes with high z-scores (Doniger et al., 2003) are grouped with ontology (Figures 5C,D).

Genes highly expressed in young compared to old peripheral retina.

Gene title Gene symbol GO biological process term Young vs. older periphery gene expression fold-change p-Value
Heat shock 70 kDa protein 6 (HSP70B′) HSPA6 Response to stress; response to unfolded protein 9.2 1.54E−02
Histone cluster 1, H2bc HIST1H2BC nucleosome assembly 5.16 8.79E−03
Autocrine motility factor receptor AMFR Ubiquitin cycle; ER-associated protein catabolic process 4.69 1.39E−08
Chitinase 3-like 1 (cartilage glycoprotein-39) CHI3L1 Carbohydrate metabolic process 3.81 8.35E−03
Heat shock 70 kDa protein 1B HSPA1B Anti-apoptosis; response to stress 3.78 3.17E−03
Phorbol-12-myristate-13-acetate-induced protein 1 PMAIP1 Release of cytochrome c from mitochondria 3.69 2.91E−03
Histone cluster 2, H2aa3/histone cluster 2, H2aa4 HIST2H2AA3 Nucleosome assembly 3.61 8.23E−03
CDC14 cell division cycle 14 homolog B (S. cerevisiae) CDC14B Protein amino acid dephosphorylation 3.42 2.23E−03
Ciliary rootlet coiled-coil, rootletin-like 1 CROCCL1 Structural component of the ciliary rootlet 3.09 9.20E−05
CART prepropeptide CARTPT Activation of MAPKK activity 2.97 9.13E−03
Calcium channel, voltage-dependent, L type, alpha-1D subunit CACNA1D Ion transport 2.96 2.47E−04
Heat shock 70 kDa protein 1A HSPA1A Anti-apoptosis; response to stress 2.96 8.55E−03
Integrin, alpha 6 ITGA6 Cell-substrate junction assembly 2.95 9.69E−03
Glutathione-S-transferase theta 1 GSTT1 Glutathione metabolic process 2.94 1.97E−03
Histone cluster 1, H2bh HIST1H2BH Nucleosome assembly 2.94 1.68E−03
GUF1 GTPase homolog (S. cerevisiae) GUF1 Nucleotide binding 2.92 5.45E−05
Syntaxin binding protein 6 (amisyn) STXBP6 Vesicle-mediated transport 2.92 9.20E−04
Growth arrest and DNA-damage-inducible, gamma GADD45G Activation of MAPKKK activity; response to stress; cell differentiation 2.84 8.31E−03
SLIT-ROBO Rho GTPase activating protein 1 SRGAP1 Signal transduction 2.73 5.44E−04
Spectrin, beta, non-erythrocytic 1 SPTBN1 Barbed-end actin filament capping 2.7 7.17E−05
Vitronectin VTN Inflammatory response pathway; histidine biosynthetic process 2.6 8.44E−03
Enhancer of polycomb homolog 1 (Drosophila) EPC1 Regulation of cell growth; transcription 2.54 2.59E−03
Choroideremia (Rab escort protein 1) CHM Blood vessel development; visual perception 2.49 1.49E−03
Monooxygenase, DBH-like 1 MOXD1 Histidine catabolism; catecholamine metabolism 2.44 6.69E−04
Sideroflexin 4 SFXN4 Protein biosynthesis; transport; ion transport 2.42 5.52E−03
ATG9 autophagy related 9 homolog B ATG9B Autophagic vacuole formation 2.37 7.15E−03
Mdm2, transformed 3T3 cell double minute 2 MDM2 Negative regulation of transcription 2.37 9.13E−03
Fatty acid binding protein 5 (psoriasis-associated) FABP5 Lipid metabolic process 2.36 3.22E−03
Ring finger protein 103 RNF103 Central nervous system development 2.35 8.83E−03
Solute carrier family 20 (phosphate transporter), member 1 SLC20A1 Phosphate metabolic process 2.35 1.42E−03
Mortality factor 4 like 2 MORF4L2 Regulation of cell growth 2.31 3.55E−02
Secreted frizzled-related protein 2 SFRP2 Somitogenesis, Wnt signaling pathway 2.31 3.75E−03
Zinc finger and BTB domain containing 24 ZBTB24 Cellular biopolymer biosynthetic process 2.31 8.73E−03
Zinc finger protein 664 ZNF664 Regulation of transcription, DNA-dependent 2.29 5.14E−03
RNA binding motif protein 4 RBM4 mRNA processing; RNA splicing 2.28 6.20E−03
Protein tyrosine phosphatase, receptor type, G PTPRG Protein amino acid dephosphorylation 2.27 2.51E−02
Prostaglandin reductase 1 PTGR1 Leukotriene metabolic process 2.26 4.13E−03
Quaking homolog, KH domain RNA binding (mouse) QKI Multicellular organismal development 2.25 6.86E−05
Neuronal PAS domain protein 4 NPAS4 Regulation of transcription, DNA-dependent 2.19 3.13E−03
Hypothetical protein KIAA1434 RP5-1022P6.2 Carbohydrate metabolic process 2.17 2.33E−06
Growth associated protein 43 GAP43 Regulation of cell growth 2.16 9.22E−03
Musashi homolog 2 (Drosophila) MSI2 Nucleotide binding 2.16 9.72E−03
Phosphodiesterase 4D interacting protein (myomegalin) PDE4DIP Cytoskeleton organization 2.16 4.60E−06
SVOP-like SVOPL Establishment of localization 2.16 3.48E−04
Ubiquitin-like modifier activating enzyme 6 UBA6 Protein modification process 2.13 5.69E−03
Serine/threonine kinase receptor associated protein STRAP mRNA processing 2.12 2.17E−03
Rap guanine nucleotide exchange factor (GEF) 2 RAPGEF2 MAPKKK cascade 2.1 9.72E−10
Exportin 1 (CRM1 homolog, yeast) XPO1 Protein import into nucleus, docking 2.09 1.60E−03
Ring finger protein 12 RNF12 Regulation of transcription, DNA-dependent 2.02 1.88E−03
Splicing factor, arginine/serine-rich 1 (splicing factor 2, alternate splicing factor) SFRS1 Nuclear mRNA splicing, via spliceosome 2.02 2.68E−03
Solute carrier family 6 (neurotransmitter transporter, GABA), member 13 SLC6A13 Neurotransmitter transport 2.01 1.77E−03
5-Nucleotidase, ecto (CD73) NT5E DNA metabolic process 2.00 9.69E−03

For changes in gene expression level we used a cutoff of >2.0-fold higher expression level in young vs. older peripheral retina (p < 0.05, Benjamini and Hochberg adjusted Student’s t-test; expression level >50 on densitometry).

Genes highly expressed in old compared to young peripheral retina.

Gene title Gene symbol GO biological process term Older vs. young periphery gene expression fold-change p-Value
Ectonucleotide pyrophosphatase/phosphodiesterase 2 (autotaxin) ENPP2 Phosphate metabolic process 3.45 9.41E−05
Cholecystokinin CCK Neuron migration 3.42 1.38E−04
Sarcolipin SLN Regulation of calcium ion transport 3.13 1.98E−04
Ribosomal protein S26 RPS26 Negative regulation of RNA splicing 2.99 1.42E−07
2-Oxoglutarate and iron-dependent oxygenase domain containing 1 OGFOD1 Protein metabolic process 2.98 9.68E−03
Laminin, alpha 3 LAMA3 Cell adhesion 2.96 2.20E−04
Zinc finger protein 43 ZNF43 Cellular biopolymer biosynthetic process 2.95 1.17E−03
Metallothionein 1 M MT1M Copper ion binding 2.94 6.54E−03
Ribosomal protein L31 RPL31 Biopolymer biosynthetic process 2.92 3.08E−04
Leucine rich repeat containing 57 LRRC57 Protein binding 2.9 9.45E−04
Peptidase inhibitor 15 PI15 Endopeptidase inhibitor activity 2.9 6.76E−05
Matrix-remodeling associated 7 MXRA7 Integral to membrane 2.71 1.41E−03
Ras suppressor protein 1 RSU1 Ras protein signal transduction 2.64 2.15E−03
Tudor domain containing 6 TDRD6 Germ cell development 2.53 2.82E−10
Zinc finger and BTB domain containing 1 ZBTB1 Transcription, DNA-dependent 2.52 2.04E−03
Cell division cycle 42 (GTP binding protein, 25 kDa) CDC42 Small GTPase mediated signal transduction 2.49 1.07E−03
REV1 homolog (S. cerevisiae) REV1 DNA repair; response to UV; response to DNA damage 2.46 2.00E−04
Ras responsive element binding protein 1 RREB1 Ras protein signal transduction 2.41 5.15E−08
Growth arrest-specific 7 GAS7 Cell cycle arrest 2.39 1.12E−04
Myo-inositol 1-phosphate synthase A1 ISYNA1 Inositol biosynthetic process 2.36 9.41E−03
Thymidylate synthetase TYMS Nucleobase, nucleoside, nucleotide, and nucleic acid metabolic process 2.36 9.37E−04
Rho GTPase activating protein 29 ARHGAP29 Rho protein signal transduction 2.31 3.53E−04
Zinc finger, DBF-type containing 2 ZDBF2 Nucleic acid binding 2.17 1.68E−04
Pyruvate dehydrogenase phosphatase isoenzyme 2 PDP2 Protein amino acid dephosphorylation 2.11 6.79E−06
Chromosome 18 open reading frame 1 C18orf1 Intrinsic to membrane 2.08 4.66E−05
Synovial sarcoma translocation, chromosome 18 SS18 Intracellular membrane-bounded organelle 2.05 3.43E−03
Solute carrier family 6 (neurotransmitter transporter, taurine), member 6 SLC6A6 Beta-alanine transport 2.03 3.64E−02
Crystallin, mu CRYM Visual perception 2.02 6.02E−04
Fatty acid binding protein 4, adipocyte FABP4 Cytokine production 2.02 7.35E−04
Heterogeneous nuclear ribonucleoprotein U (scaffold attachment factor A) HNRNPU Nuclear mRNA splicing, via spliceosome 2.02 4.53E−03
Doublecortex; lissencephaly, X-linked (doublecortin) DCX Neuron migration 2.01 1.67E−03
Enhancer of zeste homolog 1 (Drosophila) EZH1 Cellular biopolymer biosynthetic process 2.01 2.44E−04
Metallothionein 1G MT1G Copper ion binding 2.01 2.07E−03
NLR family, pyrin domain containing 2 NLRP2 Apoptosis, positive regulation of caspase activity 2.00 3.32E−03

For changes in gene expression level we used a cutoff of >2.0-fold higher expression level in old vs. young peripheral retina (p < 0.05, Benjamini and Hochberg adjusted Student’s t-test; expression level >50 on densitometry).

 Selective quantitative RT-PCR

We then performed semi-quantitative RT-PCR on several selected genes that were altered in the microarray data that had played a role in retinal survival, cellular apoptosis, or were involved in the Wnt pathway. These genes code for the X-linked inhibitor of apoptosis (XAF1, Renwick et al., 2006), cadherin 8 (CDH8, Chen and Ma, 2007), protein tyrosine kinase-2 (PTK2, Finnemann, 2003), brain-derived neurotrophic factor (BDNF, Wilson et al., 2007), nuclear receptor co-repressor 2 (NCOR2, Tsai et al., 2004; Jepsen et al., 2007), chloride intracellular channel 4 (CLIC4, Chen et al., 2004), DKK1, FZD10, and SFRP2 (Robitaille et al., 2002; Kubo et al., 2003; Liu et al., 2007). In all cases, the changes in expression level detected with the microarray data are in the same direction (i.e., up or down) as the changes in expression level detected by qRT-PCR. There is reasonable agreement between the relative expression level of each of these genes when comparing younger vs. older samples as detected by microarray data and qRT-PCR (Table 2).

 Discussion

We have used the Affymetrix DNA microarray chip U133 plus 2 to study the gene expression profile of the human retina as a function of age and topographic location (macula vs. peripheral retina). We were able to confirm the microarray findings with qRT-PCR of selected genes. There is some variation in the exact relative expression level between qRT-PCR and microarray data, but in every case, the relative expression levels using the microarray data and qRT-PCR were always in the same direction (Table 2).

We were able to detect the presence of approximately 26,700 out of 54,600 gene probes present on the Affymetrix Human Genome U133 plus 2 chip in all four groups; namely, young macula, young periphery, older macula, and older periphery. The number of gene probes that we detected in human retina is about 10,000 more than those reported in RNA extracted from human retinal ganglion cells (Kim et al., 2006). This was probably due to the fact that our samples contained multiple retinal cell types. A priori we reasoned that aging of the macula and/or periphery might increase either the number of genes expressed throughout the retina or the variation in the number of genes expressed in older peripheral vs. macular samples; however, there was no significant difference in the average number or standard deviation of the number of genes expressed in young vs. older macular or peripheral samples (data not shown).

Hierarchical clustering analysis is a statistical technique used to sort heterogeneous samples into several distinct groups that contain genes with similar expression patterns (Eisen et al., 1998; Krajewski and Bocianowski, 2002). Clustering analysis suggests that aging changes the expression profile more than the location of retina (macular vs. peripheral; Figure 4). To circumvent the possibility that the macula from a donor is simply clustering with the periphery from the same donor, this analysis was repeated with a smaller subset of eyes so that young macula and young peripheral samples were obtained from unrelated individuals, as were young and old peripheral samples. This did not alter the clustering pattern seen in Figure 4 (data not shown).

Previous authors have also sought to determine the retinal gene expression profile as a function of age in both macular and peripheral retina using smaller sample sizes (Yoshida et al., 2002; Hornan et al., 2007; Ben-Shlomo et al., 2008). Yoshida et al. developed gene expression profiles of young and elderly human retinas using microarray slides containing 2400 human genes that were primarily neuronal. More than 50% hybridized to the retinal cDNA targets. Northern blot analysis and qRT-PCR results confirmed the changes in expression in 8 of 10 genes examined, including an increase in IFN-responsive transcription factor subunit (ISGF3G), creatine kinase B (CKB), and pancreatic amylase (AMY2A), and a decrease in TGF-beta receptor interacting protein 1 (TRIP1), LPS-induced TNF-alpha factor (PIG7), alpha-1 (E)-catenin (CTNNA1), ubiquitin hydrolase (USP9X), GABA receptor beta-3 subunit (GABRB3), and alpha-1 Type VII collagen (COL7A1). Hornan et al. compared the expression profile of cone-rich macular vs. rod rich peripheral retina using 2–4 mm retinal punches from human retina, and demonstrated that macula transcripts were enriched for nuclear pore complex interacting protein (NPIP) and eukaryotic translation initiation factor 2 alpha kinase (GCN2), with these protein products being detected in cone outer segments. Ben-Shlomo et al. examined the gene expression profile over the first 20 weeks of life in rat retina dissected during the first 20 weeks of life at 2 different time points and identified 603 differentially expressed genes, which were grouped into six clusters based on changes in expression levels during the first 20 weeks of life. A bioinformatic analysis of these clusters revealed sets of genes encoding proteins with functions relevant to retinal maturation, such as potassium, sodium, calcium, and chloride channels, synaptic vesicle transport, and axonogenesis. Schippert et al. (2009) compared the expression profile of wild type and Egr-1 knockout mice, which have longer eyes and a more myopic refractive error compared to their wild-types. Changes in expression were confirmed in four genes by RT-PCR, including nuclear prelamin A recognition factor (Narf), oxoglutarate dehydrogenase (Ogdh), selenium binding protein 1 (Selenbp1), and Pcdhb9. Glenn et al. (2009) showed that glycation of the basement membrane causes a significant reduction in cathepsin-D activity in ARPE-19 (p < 0.05) and an increase in lipofuscin accumulation (p < 0.01). Chen et al. (2008) compared the transcriptional profiles of the RPE/choroid from young and old mice. There were 315 genes differentially expressed with age; most of these genes were related to immune responses and inflammatory activity. There was increased gene expression and protein levels of leukocyte attracting signal, chemokine ligand 2 (Ccl2) in aged RPE/choroid. These studies cover a wide range of conditions, including using different array chips, and comparing young vs. old, and macula vs. peripheral, in several species, including humans. Despite these differences, our data (Tables 3, 4, and 6) is consistent with prior published studies showing up-regulation of HNRPF (heterogeneous nuclear ribonucleoprotein F) and ENO3 (Muscle specific enolase) in older retina; (Yoshida et al., 2002) higher expression levels of RHO (rhodopsin) in periphery; and higher expression levels of HDAC9 (histone deacetylase 9) and SRGAP2 (Rho GTPase activating protein 2) in the macula (Hornan et al., 2007).

It is interesting to note that there are only 24 genes expressed at higher levels in the periphery vs. macular retina and 3 of these genes (namely, DKK1, FZD10, and SFRP2) encode for protein products that inhibit the Wnt receptor signaling pathway (Table 4). There are three major types of inhibitors of this pathway in Xenopus that have human homologs, including the secreted frizzled-related proteins (sFRPs; Melkonyan et al., 1997), Wnt-inhibitory factor-1 (WIF-1; Hsieh et al., 1999), and Dickkopf (DKK), which also includes four known human proteins DKK1–4 (Krupnik et al., 1999). Wnt ligands belong to a highly conserved family of oncogenes expressed in species ranging from the fruit fly to man (McMahon and Moon, 1989; Busse and Seguin, 1993; Magee, 1995). Wnt signaling controls many events during embryogenesis and exerts significant regulation of cell morphology, proliferation, motility, and cell fate (Parr and McMahon, 1994; Siegfried and Perrimon, 1994; Turnbull et al., 1995). Inappropriate activation of the Wnt signaling pathway has been observed in several human cancers (Spink et al., 2000). Inhibition of the Wnt pathway is correlated with preventing cells from moving into a regenerative state, and Wnt signaling is important in transdifferentiation of ciliary margin stem cells into neural retina at the ciliary marginal zone (Robitaille et al., 2002; Kubo et al., 2003; Liu et al., 2007). Addition of Wnt3a to cultures of ciliary margin cells increased the number of proliferating cells and allowed the cells to maintain their multilineage potential (Inoue et al., 2006; Liu et al., 2007). Wnt signaling may provide a therapeutic strategy for in vitro expansion or in vivo activation of adult retinal stem cells (Inoue et al., 2006; Liu et al., 2007). Our observation that DKK1, FZD10, and SFRP2 are expressed at higher levels in the peripheral retina than those in macular retina (Table 4) suggests that there is inhibition of the Wnt signaling pathway in the periphery compared to the macular human retina. A potential strategy for cell replacement in retinal disorders, including retinitis pigmentosa (Pruett, 1983; Smith et al., 2009), is to activate this pathway in the peripheral retina and ciliary marginal zone.

We were able to detect genes whose expression levels change with aging of the human neural retina, and many of these genes appear to be related to cell growth, proliferation, and survival. For instance, aging decreases the expression level of genes known to be important for retinal survival/protection such as X-linked inhibitor of apoptosis (XAF1), Cadherin (CDH8), PTK2 protein tyrosine kinase (PTK2), and BDNF. Aging increases the expression of genes related to aging and apoptosis, such as genes coding for the nuclear receptor co-repressor 2 (NCOR2) and chloride intracellular channel 4 (CLIC4; Tables 2, 5, and 6). These changes may explain the increasing susceptibility of the human retina to some diseases as patient age increases, such as AMD and glaucoma. Retinal aging is also associated with changes in expression of genes involved in the complement cascade; the relationship of altered expression of these genes to the development of age-related diseases such as AMD remains to be elucidated. Any individual change or combination of changes may be responsible for altering retinal gene expression (Cai et al., 2006; Han et al., 2007).

Our gene ontology analysis (Wu et al., 2006; Noel et al., 2007; Grigoryev et al., 2008) reveals genes whose expression levels change during retina aging are involved in cellular metabolism, regulation of the cell cycle, cell adhesion, and other biological pathways (Figure 5). Interestingly, up-regulated genes involved with cell growth were detected only within younger macula and peripheral retina (Figures 5A,C) but not in older macula and peripheral retina (Figures 5B,D).

We recognize that an intrinsic limitation of using human tissue is the potential RNA degradation that can occur between death and RNA isolation; in our view this limitation is counterbalanced by the fact that the value of data obtained from human retina cannot be replaced by other means. Several facts suggest that retinal RNA can be relatively stable between death and RNA isolation within the time frame we used. First, Malik et al. (2003) conducted an RNA stability study on neural retina and RPE and concluded that the RNA from neural retina was stable up to 48 h after death. In the current study we used a cutoff of 32 h for the death-to-RNA harvesting time, which is within the period of time that retinal RNA is stable. Although proteins and RNA degrade by different mechanisms, there is also tremendous stability of the retinal proteome after harvesting, as there was no significant time-dependent change in intensity for >95% of retinal proteins examined up to 48 h postmortem (Ethen et al., 2006). Second, we measured the relative intensity of the 28S and 18S RNA bands and demonstrated that there was no significant RNA degradation at the time of RNA isolation (data not shown). Third, we demonstrated that there is no significant degradation of the signal from housekeeping genes, as revealed by the stability of the hybridization signals from 3′, middle, and 5′ fragment of mRNA of housekeeping genes coded in the Affymetrix DNA chips (Figures 1 and 3). Fourth, we did not introduce any bias by handling younger and older tissue differently, as there is no correlation between donor age and either death-to-enucleation or death-to-RNA isolation time (Figure 2).

There are other potential limitations to our study. First, it is likely that there is significant patient-to-patient variation in gene expression profiling, particularly since our samples may include patients with normal eyes as well as patients with age-related disease or dysfunction. Second, we harvested full-thickness human retina for this analysis. Thus, mixed retinal cell types were present within our full-thickness retinal punches. Additional studies are necessary and planned to determine which cell(s) contribute to the changes in gene expression seen here. Third, there is incomplete correlation between the transcriptome and proteomics of many tissues (Hack, 2004; Baginsky et al., 2005; Cox et al., 2007; Fagan et al., 2007; Hesketh et al., 2007; Dihal et al., 2008). Additional studies are necessary to determine the effects of aging and topographic location on retinal proteomics. Fourth, our study does not consider the effects of aging and/or topographic location on post-translational protein modification; these effects have been shown to be significant in other ocular tissues, including lens (Takemoto and Gopalakrishnan, 1994). As with any other gene expression studies we cannot discern whether the gene expression changes that we observe are primary or secondary. Despite these limitations we have obtained important information on changes in the gene expression that occur in aging human retina. Additional studies are required to determine the role of specific alterations in the transcriptome in the pathogenesis of age-related ocular diseases such as AMD.

 Conflict of Interest Statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Supported by Research to Prevent Blindness, Robert L. Burch III Fund, Retina Society, and the Foundation Fighting Blindness.

 References Archer K. J. Guennel T. (2006). An application for assessing quality of RNA hybridized to affymetrix GeneChips. Bioinformatics 22, 2699–2701.10.1093/bioinformatics/btl45916935927 Ashburner M. Ball C. A. Blake J. A. Botstein D. Butler H. Cherry J. M. Davis A. P. Dolinski K. Dwight S. S. Eppig J. T. Harris M. A. Hill D. P. Issel-Tarver L. Kasarskis A. Lewis S. Matese J. C. Richardson J. E. Ringwald M. Rubin G. M. Sherlock G. (2000). Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat. Genet. 25, 25–29.10.1038/7555610802651 Baginsky S. Kleffmann T. Von Zychlinski A. Gruissem W. (2005). Analysis of shotgun proteomics and RNA profiling data from Arabidopsis thaliana chloroplasts. J. Proteome Res. 4, 637–640.10.1021/pr049764u15822946 Benjamini Y. Drai D. Elmer G. Kafkafi N. Golani I. (2001). Controlling the false discovery rate in behavior genetics research. Behav. Brain Res. 125, 279–284.10.1016/S0166-4328(01)00297-211682119 Ben-Shlomo G. Ofri R. Bandah D. Rosner M. Sharon D. (2008). Microarray-based gene expression analysis during retinal maturation of albino rats. Graefes Arch. Clin. Exp. Ophthalmol. 246, 693–702.10.1007/s00417-008-0772-018286297 Busse U. Seguin C. (1993). Molecular analysis of the Wnt-1 proto-oncogene in Ambystoma mexicanum (axolotl) embryos. Differentiation 53, 7–15.10.1111/j.1432-0436.1993.tb00640.x8508949 Cai H. Del Priore L. V. (2006). Bruch membrane aging alters the gene expression profile of human retinal pigment epithelium. Curr. Eye Res. 31, 181–189.10.1080/0271368050051462816500769 Cai H. Shin M. C. Tezel T. H. Kaplan H. J. Del Priore L. V. (2006). Use of iris pigment epithelium to replace retinal pigment epithelium in age-related macular degeneration: a gene expression analysis. Arch. Ophthalmol. 124, 1276–1285.10.1001/archopht.124.9.127616966623 Chader G. J. (2002). Animal models in research on retinal degenerations: past progress and future hope. Vision Res. 42, 393–399.10.1016/S0042-6989(01)00212-711853755 Chen H. Liu B. Lukas T. J. Neufeld A. H. (2008). The aged retinal pigment epithelium/choroid: a potential substratum for the pathogenesis of age-related macular degeneration. PLoS ONE 3, e2339.10.1371/journal.pone.0002339 Chen H. J. Ma Z. Z. (2007). N-cadherin expression in a rat model of retinal detachment and reattachment. Invest. Ophthalmol. Vis. Sci. 48, 1832–1838.10.1167/iovs.06-092817389518 Chen L. Wu W. Dentchev T. Zeng Y. Wang J. Tsui I. Tobias J. W. Bennett J. Baldwin D. Dunaief J. L. (2004). Light damage induced changes in mouse retinal gene expression. Exp. Eye Res. 79, 239–247.10.1016/j.exer.2004.05.00415325571 Chowers I. Gunatilaka T. L. Farkas R. H. Qian J. Hackam A. S. Duh E. Kageyama M. Wang C. Vora A. Campochiaro P. A. Zack D. J. (2003). Identification of novel genes preferentially expressed in the retina using a custom human retina cDNA microarray. Invest. Ophthalmol. Vis. Sci. 44, 3732–3741.10.1167/iovs.02-108012939286 Cox B. Kislinger T. Wigle D. A. Kannan A. Brown K. Okubo T. Hogan B. Jurisica I. Frey B. Rossant J. Emili A. (2007). Integrated proteomic and transcriptomic profiling of mouse lung development and Nmyc target genes. Mol. Syst. Biol. 3, 109.10.1038/msb410015117486137 Del Priore L. V. Tezel T. H. (1998). Reattachment rate of human retinal pigment epithelium to layers of human Bruch’s membrane. Arch. Ophthalmol. 116, 335–341.9514487 Dihal A. A. Van Der Woude H. Hendriksen P. J. Charif H. Dekker L. J. Ijsselstijn L. De Boer V. C. Alink G. M. Burgers P. C. Rietjens I. M. Woutersen R. A. Stierum R. H. (2008). Transcriptome and proteome profiling of colon mucosa from quercetin fed F344 rats point to tumor preventive mechanisms, increased mitochondrial fatty acid degradation and decreased glycolysis. Proteomics 8, 45–61.10.1002/pmic.20070036418095365 Doniger S. W. Salomonis N. Dahlquist K. D. Vranizan K. Lawlor S. C. Conklin B. R. (2003). MAPPFinder: using gene ontology and GenMAPP to create a global gene-expression profile from microarray data. Genome Biol. 4, R7.10.1186/gb-2003-4-1-r712540299 Eisen M. B. Spellman P. T. Brown P. O. Botstein D. (1998). Cluster analysis and display of genome-wide expression patterns. Proc. Natl. Acad. Sci. U.S.A. 95, 14863–14868.10.1073/pnas.95.25.148639843981 Ethen C. M. Reilly C. Feng X. Olsen T. W. Ferrington D. A. (2006). The proteome of central and peripheral retina with progression of age-related macular degeneration. Invest. Ophthalmol. Vis. Sci. 47, 2280–2290.10.1167/iovs.05-139516723435 Fagan A. Culhane A. C. Higgins D. G. (2007). A multivariate analysis approach to the integration of proteomic and gene expression data. Proteomics 7, 2162–2171.10.1002/pmic.20060089817549791 Finnemann S. C. (2003). Focal adhesion kinase signaling promotes phagocytosis of integrin-bound photoreceptors. EMBO J. 22, 4143–4154.10.1093/emboj/cdg41612912913 Glenn J. V. Mahaffy H. Wu K. Smith G. Nagai R. Simpson D. A. Boulton M. E. Stitt A. W. (2009). Advanced glycation end product (AGE) accumulation on Bruch’s membrane: links to age-related RPE dysfunction. Invest. Ophthalmol. Vis. Sci. 50, 441–451.10.1167/iovs.08-172418676633 Gong J. Sagiv O. Cai H. Tsang S. H. Del Priore L. V. (2008). Effects of extracellular matrix and neighboring cells on induction of human embryonic stem cells into retinal or retinal pigment epithelial progenitors. Exp. Eye Res. 86, 957–965.10.1016/j.exer.2008.03.01418472095 Grigoryev D. N. Mathai S. C. Fisher M. R. Girgis R. E. Zaiman A. L. Housten-Harris T. Cheadle C. Gao L. Hummers L. K. Champion H. C. Garcia J. G. Wigley F. M. Tuder R. M. Barnes K. C. Hassoun P. M. (2008). Identification of candidate genes in scleroderma-related pulmonary arterial hypertension. Transl. Res. 151, 197–207.10.1016/j.trsl.2007.12.01018355767 Hack C. J. (2004). Integrated transcriptome and proteome data: the challenges ahead. Brief. Funct. Genomic. Proteomic. 3, 212–219.10.1093/bfgp/3.3.21215642185 Han M. Giese G. Schmitz-Valckenberg S. Bindewald-Wittich A. Holz F. G. Yu J. Bille J. F. Niemz M. H. (2007). Age-related structural abnormalities in the human retina-choroid complex revealed by two-photon excited autofluorescence imaging. J. Biomed. Opt. 12, 024012.10.1117/1.243570017477727 Hesketh A. Bucca G. Laing E. Flett F. Hotchkiss G. Smith C. P. Chater K. F. (2007). New pleiotropic effects of eliminating a rare tRNA from Streptomyces coelicolor, revealed by combined proteomic and transcriptomic analysis of liquid cultures. BMC Genomics 8, 261.10.1186/1471-2164-8-261 Hollborn M. Tenckhoff S. Jahn K. Iandiev I. Biedermann B. Schnurrbusch U. E. Limb G. A. Reichenbach A. Wolf S. Wiedemann P. Kohen L. Bringmann A. (2005). Changes in retinal gene expression in proliferative vitreoretinopathy: glial cell expression of HB-EGF. Mol. Vis. 11, 397–413.15988409 Hornan D. M. Peirson S. N. Hardcastle A. J. Molday R. S. Cheetham M. E. Webster A. R. (2007). Novel retinal and cone photoreceptor transcripts revealed by human macular expression profiling. Invest. Ophthalmol. Vis. Sci. 48, 5388–5396.10.1167/iovs.07-035518055785 Hsieh J. C. Kodjabachian L. Rebbert M. L. Rattner A. Smallwood P. M. Samos C. H. Nusse R. Dawid I. B. Nathans J. (1999). A new secreted protein that binds to Wnt proteins and inhibits their activities. Nature 398, 431–436.10.1038/1889910201374 Hubbell E. Liu W. M. Mei R. (2002). Robust estimators for expression analysis. Bioinformatics 18, 1585–1592.10.1093/bioinformatics/18.12.158512490442 Inoue T. Kagawa T. Fukushima M. Shimizu T. Yoshinaga Y. Takada S. Tanihara H. Taga T. (2006). Activation of canonical Wnt pathway promotes proliferation of retinal stem cells derived from adult mouse ciliary margin. Stem Cells 24, 95–104.10.1634/stemcells.2005-012416223856 Jepsen K. Solum D. Zhou T. Mcevilly R. J. Kim H. J. Glass C. K. Hermanson O. Rosenfeld M. G. (2007). SMRT-mediated repression of an H3K27 demethylase in progression from neural stem cell to neuron. Nature 450, 415–419.10.1038/nature0627017928865 Kim C. Y. Kuehn M. H. Clark A. F. Kwon Y. H. (2006). Gene expression profile of the adult human retinal ganglion cell layer. Mol. Vis. 12, 1640–1648.17200664 Krajewski P. Bocianowski J. (2002). Statistical methods for microarray assays. J. Appl. Genet. 43, 269–278.12177516 Krupnik V. E. Sharp J. D. Jiang C. Robison K. Chickering T. W. Amaravadi L. Brown D. E. Guyot D. Mays G. Leiby K. Chang B. Duong T. Goodearl A. D. Gearing D. P. Sokol S. Y. Mccarthy S. A. (1999). Functional and structural diversity of the human Dickkopf gene family. Gene 238, 301–313.10.1016/S0378-1119(99)00365-010570958 Kubo F. Takeichi M. Nakagawa S. (2003). Wnt2b controls retinal cell differentiation at the ciliary marginal zone. Development 130, 587–598.10.1242/dev.0024412490564 Kurji K. H. Cui J. Z. Lin T. Harriman D. Prasad S. S. Kojic L. Matsubara J. A. (2009). Microarray analysis identifies changes in inflammatory gene expression in response to amyloid-beta stimulation of cultured human retinal pigment epithelial cells. Invest. Ophthalmol. Vis. Sci. 51, 1151–1163.10.1167/iovs.09-362219797223 Liu H. Xu S. Wang Y. Mazerolle C. Thurig S. Coles B. L. Ren J. C. Taketo M. M. Van Der Kooy D. Wallace V. A. (2007). Ciliary margin transdifferentiation from neural retina is controlled by canonical Wnt signaling. Dev. Biol. 308, 54–67.10.1016/j.ydbio.2007.04.05217574231 Magee A. I. (1995). Cell adhesion molecules and intracellular signalling: from fly to man. Cell. Signal. 7, 165–170.10.1016/0898-6568(94)00090-X7662505 Malik K. J. Chen C. D. Olsen T. W. (2003). Stability of RNA from the retina and retinal pigment epithelium in a porcine model simulating human eye bank conditions. Invest. Ophthalmol. Vis. Sci. 44, 2730–2735.10.1167/iovs.02-112012766080 McMahon A. P. Moon R. T. (1989). int-1 – a proto-oncogene involved in cell signalling. Development 107 (Suppl.), 161–167.2534596 Melkonyan H. S. Chang W. C. Shapiro J. P. Mahadevappa M. Fitzpatrick P. A. Kiefer M. C. Tomei L. D. Umansky S. R. (1997). SARPs: a family of secreted apoptosis-related proteins. Proc. Natl. Acad. Sci. U.S.A. 94, 13636–13641.10.1073/pnas.94.25.136369391078 Nag T. C. Wadhwa S. Chaudhury S. (2006). The occurrence of cone inclusions in the ageing human retina and their possible effect upon vision: an electron microscope study. Brain Res. Bull. 71, 224–232.10.1016/j.brainresbull.2006.09.00717113950 Noel S. Sharma S. Shanker R. Rath S. K. (2007). Primaquine-induced differential gene expression analysis in mice liver using DNA microarrays. Toxicology 239, 96–107.10.1016/j.tox.2007.06.09817686563 Parr B. A. McMahon A. P. (1994). Wnt genes and vertebrate development. Curr. Opin. Genet. Dev. 4, 523–528.10.1016/0959-437X(94)90067-D7950319 Pruett R. C. (1983). Retinitis pigmentosa: clinical observations and correlations. Trans. Am. Ophthalmol. Soc. 81, 693–735.6676982 Radeke M. J. Peterson K. E. Johnson L. V. Anderson D. H. (2007). Disease susceptibility of the human macula: differential gene transcription in the retinal pigmented epithelium/choroid. Exp. Eye Res. 85, 366–380.10.1016/j.exer.2007.05.00617662275 Renwick J. Narang M. A. Coupland S. G. Xuan J. Y. Baker A. N. Brousseau J. Petrin D. Munger R. Leonard B. C. Hauswirth W. W. Korneluk R. G. Tsilfidis C. (2006). XIAP-mediated neuroprotection in retinal ischemia. Gene Ther. 13, 339–347.10.1038/sj.gt.330268316307001 Robitaille J. Macdonald M. L. Kaykas A. Sheldahl L. C. Zeisler J. Dube M. P. Zhang L. H. Singaraja R. R. Guernsey D. L. Zheng B. Siebert L. F. Hoskin-Mott A. Trese M. T. Pimstone S. N. Shastry B. S. Moon R. T. Hayden M. R. Goldberg Y. P. Samuels M. E. (2002). Mutant frizzled-4 disrupts retinal angiogenesis in familial exudative vitreoretinopathy. Nat. Genet. 32, 326–330.10.1038/ng95712172548 Schippert R. Schaeffel F. Feldkaemper M. P. (2009). Microarray analysis of retinal gene expression in Egr-1 knockout mice. Mol. Vis. 15, 2720–2739.20019881 Siegfried E. Perrimon N. (1994). Drosophila wingless: a paradigm for the function and mechanism of Wnt signaling. Bioessays 16, 395–404.10.1002/bies.9501606078080429 Smith A. J. Bainbridge J. W. Ali R. R. (2009). Prospects for retinal gene replacement therapy. Trends Genet. 25, 156–165.10.1016/j.tig.2009.09.00119303164 Spink K. E. Polakis P. Weis W. I. (2000). Structural basis of the Axin-adenomatous polyposis coli interaction. EMBO J. 19, 2270–2279.10.1093/emboj/19.10.227010811618 Spraul C. W. Lang G. E. Grossniklaus H. E. Lang G. K. (1999). Histologic and morphometric analysis of the choroid, Bruch’s membrane, and retinal pigment epithelium in postmortem eyes with age-related macular degeneration and histologic examination of surgically excised choroidal neovascular membranes. Surv. Ophthalmol. 44 (Suppl. 1), S10–S32.10.1016/S0039-6257(99)00086-710548114 Stadler Z. K. Come S. E. (2009). Review of gene-expression profiling and its clinical use in breast cancer. Crit. Rev. Oncol. Hematol. 69, 1–11.10.1016/j.critrevonc.2008.05.00418614375 Takemoto L. Gopalakrishnan S. (1994). Alpha-A crystallin: quantitation of C-terminal modification during lens aging. Curr. Eye Res. 13, 879–883.10.3109/027136894090150907720395 Tsai C. C. Kao H. Y. Mitzutani A. Banayo E. Rajan H. Mckeown M. Evans R. M. (2004). Ataxin 1, a SCA1 neurodegenerative disorder protein, is functionally linked to the silencing mediator of retinoid and thyroid hormone receptors. Proc. Natl. Acad. Sci. U.S.A. 101, 4047–4052.10.1073/pnas.040266210115016912 Turnbull D. H. Bloomfield T. S. Baldwin H. S. Foster F. S. Joyner A. L. (1995). Ultrasound backscatter microscope analysis of early mouse embryonic brain development. Proc. Natl. Acad. Sci. U.S.A. 92, 2239–2243.10.1073/pnas.92.6.22397892254 van Soest S. S. De Wit G. M. Essing A. H. Ten Brink J. B. Kamphuis W. De Jong P. T. Bergen A. A. (2007). Comparison of human retinal pigment epithelium gene expression in macula and periphery highlights potential topographic differences in Bruch’s membrane. Mol. Vis. 13, 1608–1617.17893662 Wilson R. B. Kunchithapautham K. Rohrer B. (2007). Paradoxical role of BDNF: BDNF± retinas are protected against light damage-mediated stress. Invest. Ophthalmol. Vis. Sci. 48, 2877–2886.10.1167/iovs.06-107917525224 Wistow G. Bernstein S. L. Wyatt M. K. Ray S. Behal A. Touchman J. W. Bouffard G. Smith D. Peterson K. (2002). Expressed sequence tag analysis of human retina for the NEIBank project: retbindin, an abundant, novel retinal cDNA and alternative splicing of other retina-preferred gene transcripts. Mol. Vis. 8, 196–204.12107411 Wu X. Zhu L. Guo J. Zhang D. Y. Lin K. (2006). Prediction of yeast protein-protein interaction network: insights from the gene ontology and annotations. Nucleic Acids Res. 34, 2137–2150.10.1093/nar/gkl21916641319 Ye Y. Lukinova N. Fortini M. E. (1999). Neurogenic phenotypes and altered notch processing in Drosophila presenilin mutants. Nature 398, 525–529.10.1038/1909610206647 Yoshida S. Yashar B. M. Hiriyanna S. Swaroop A. (2002). Microarray analysis of gene expression in the aging human retina. Invest. Ophthalmol. Vis. Sci. 43, 2554–2560.12147584